Research: Metformin may be effective in treating breast cancer that lacks Nischarin protein

Research conducted by Suresh Alahari, PhD, Professor of Biochemistry and Genetics at LSU Health New Orleans School of Medicine, has found that metformin, a commonly prescribed drug for Type 2 Diabetes, may be effective in treating cancers that lack a protein called Nischarin.

From http://besthealthnews.com/2019/09/research-metformin-may-be-effective-in-treating-breast-cancer-that-lacks-nischarin-protein/?utm_source=rss&utm_medium=rss&utm_campaign=research-metformin-may-be-effective-in-treating-breast-cancer-that-lacks-nischarin-protein

from
https://healthnews010.wordpress.com/2019/09/20/research-metformin-may-be-effective-in-treating-breast-cancer-that-lacks-nischarin-protein/

From https://jamesjohnson10.blogspot.com/2019/09/research-metformin-may-be-effective-in.html

from
https://jamesjohnson10.wordpress.com/2019/09/20/research-metformin-may-be-effective-in-treating-breast-cancer-that-lacks-nischarin-protein/

From https://judywright2.blogspot.com/2019/09/research-metformin-may-be-effective-in.html

from
https://judywright2.wordpress.com/2019/09/20/research-metformin-may-be-effective-in-treating-breast-cancer-that-lacks-nischarin-protein/